Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Disulfiram Plus Arsenic Trioxide In Patients With Metastatic Melanoma and at Least One Prior Systemic Therapy

This study has been terminated.
(Halted because of slow accrual and lack of study funding)
Information provided by (Responsible Party):
John P. Fruehauf, University of California, Irvine Identifier:
First received: December 6, 2007
Last updated: December 6, 2016
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2012
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)